[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Biogen Inc (BIIB)

Biogen's stock is experiencing downward pressure following HSBC's downgrade to 'Reduce' and concerns over its pipeline, despite positive news on LEQEMBI's subcutaneous injection availability and favorable analyst ratings.

About Biogen Inc

Biogen Inc. is a biotechnology company focused on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.
Biogen Inc uses the ticker $BIIB for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Biogen Inc (BIIB) trading volume hit $472.5M which is XXX% higher than it's daily average.
Biogen Inc (BIIB) trading volume is up XXXXX% from the previous X months.
Biogen Inc (BIIB) social dominance is up XXXXX% from the previous week.
Biogen Inc (BIIB) posts created is up XXXXX% from the previous week.

Price: $XXXXXX

Price 24-Hour Time-Series Raw Data
The stock price is being influenced by a mix of positive developments, including LEQEMBI's subcutaneous injection availability and strong analyst ratings, countered by recent downgrades from HSBC and pipeline concerns.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%

1-Year High: $XXXXXX on 2025-11-28
1-Year Low: $XXXXXX on 2025-04-10

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Biogen Inc (BIIB) is currently AltRank #382 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX +119
X Month: XXX +100
X Months: XXX +25
X Year: XXX +123
1-Year High: XXXXX on 2025-07-18
1-Year Low: XX on 2025-01-12

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -XX
X Year: XX -X
1-Year High: XX on 2025-03-17
1-Year Low: XX on 2024-12-12

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX +26%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2025-02-12
1-Year Low: XXXXX on 2025-12-06

Engagements by network (24h): Reddit: XXX X: XXXXX YouTube: X

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +15%
X Months: XXXXX -XXXX%
X Year: XXXXXX -XXXX%
1-Year High: XXX on 2025-01-16
1-Year Low: XX on 2025-12-07

Mentions by network (24h): Reddit: XX X: XXX YouTube: X

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Biogen Inc (BIIB) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX +38%
X Months: XXXXX +67%
X Year: XXXXX +58%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-12-07

The most influential creators that mention Biogen Inc in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@PrimeTrading_	X	XXXXXX	X	XXXXX
@BreakTheCode	X	XXXXX	X	XXX
@BuyTheUgly	X	XX	X	XXX
@ArtsStocks	X	XXX	X	XXX
@SteveDJacobs	X	XXXXX	X	XXX
@bpra93	X	XXXXXX	X	XX
@AsAboveSoBelow322	X	XXXXX	X	XX
@MoneyMaker0009	X	XXX	X	XX
@Drugdoctor2014	X	XXXXX	X	XX
@mariostario2019	XX	XX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% +24%
X Months: XX% -X%
X Year: XX% +46%
1-Year High: XX% on 2025-06-28
1-Year Low: XX% on 2025-02-03

Most Supportive Themes:

LEQEMBI Availability: (45%) The availability of LEQEMBI subcutaneous injection for early Alzheimer's disease treatment.
Positive Analyst Ratings: (25%) Analysts have raised their target prices for Biogen Inc (BIIB), indicating a positive outlook.
Healthcare Sector Performance: (15%) Biogen is benefiting from a strong overall performance within the healthcare sector.

Most Critical Themes:

Patent Dispute: (5%) Biogen is involved in a patent dispute and has been ordered to pay $XXX million to Genentech.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.007%
X Month: XXXXX% +0.0076%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXX%
1-Year High: XXXXX% on 2025-01-16
1-Year Low: XXXXXX% on 2025-12-07

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-12-02
1-Year Low: XXXXX% on 2025-12-11

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$3.70%
X Month: $XXXXXXXXXXXXXX +$9.80%
X Months: $XXXXXXXXXXXXXX +$34%
X Year: $XXXXXXXXXXXXXX +$11%
1-Year High: $XXXXXXXXXXXXXX on 2025-11-28
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-10